6 TECH OUTLOOKSept-Oct 2017Editorial StaffAaron Pierce Alex D'SouzaAva GarciaHrushikesh Arun DondeJenna VegasJoshua ParkerEditorialStacey Smith Editor-in-ChiefThe case of Daraprim is still fresh in our memories as we witnessed how a price hike of the life-saving pill snowballed into a public outrage. For pharma manufacturers, regulatory bodies and peer competition were prime concerns till Martin Shkreli's decision to raise the drug price came under public scrutiny. With the source of drug material to price remaining under the scanner of public, peers, and regulatory bodies, drug manufacturers are exploring means to improve their bottom line by improvising the manufacturing methods. In tandem with the technological advancements and process methodologies, pharma manufacturing is soon to overhaul their processes and improve their solutions. Though guidelines and regulations have created an uphill journey for pharma manufacturers so far, there are signs of change. Recently, FDA set to collect more insights about how continuous manufacturing (CM) can refine drug manufacturing process and eliminate the probability of manufacturing failures. This is a welcome move as it will introduce a new approach and a departure from batch manufacturing of pills. Adoption of this methodology will give impetus on the usage of IIoT and cloud. Synergies of new technologies and methodologies will pave a path for unprecedented growth. Though pharma manufacturers have been leveraging the potential of cloud and IIoT to expedite manufacturing and reduce production cost, with the different methodologies in place, the outcome will match expectations. To simplify the things and shorten the learning curve needed to embrace aforementioned methodologies and technologies, solution providers have devised cutting-edge tools that will cater to the needs of pharma companies. In this edition, Pharma Tech Outlook brings to you companies that are at the leading edge of transforming pharmaceutical manufacturing for better outcomes through holistic solutions. Let us know your thoughts.Bracing for Process and Business EvolutionTECH OUTLOOKTECH OUTLOOKCopyright © 2017 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.SEPT - OCT - 2017Mailing AddressValleyMedia Inc.44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510 556 2402, F:510-894-8405 Sept - Oct - 2017, Vol 03 - 06 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithSalesVisualizerStephen ThomasAjay K DasPHARMACEUTICAL MANUFACTURING SPECIAL Max Wilson max.wilson@pharmatechoutlook.comT:510.556.2402*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staff
< Page 5 | Page 7 >